CLINICAL_TRIALS
trial_result
· 2020-07-07
Clinical Trial Update: A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China [Phase 2]
Summary
Phase 2 clinical trial update for Felbinac Trometamol Injection in China focusing on pain conditions; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd | Conditions: Pain | Phase 2 | Status: COMPLETED